Cargando…

Association of Kidney Function With Risk of Adverse Effects of Therapies for Atrial Fibrillation

INTRODUCTION: Atrial fibrillation (AF) is common in chronic kidney disease (CKD) and is treated with rate control medications, antiarrhythmic medications, as well as anticoagulation and procedures, each of which have associated risks. We aimed to evaluate the association of CKD status with the risks...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bansal, Nisha, Zelnick, Leila R., An, Jaejin, Harrison, Teresa N., Lee, Ming-Sum, Singer, Daniel E., Sung, Sue Hee, Fan, Dongjie, Go, Alan S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10014389/ https://www.ncbi.nlm.nih.gov/pubmed/36938096 http://dx.doi.org/10.1016/j.ekir.2022.12.002

Ejemplares similares

Incident Atrial Fibrillation and Risk of Dementia in a Diverse, Community‐Based Population
por: Bansal, Nisha, et al.
Publicado: (2023)

Incident Atrial Fibrillation and Risk of Death in Adults With Chronic Kidney Disease
por: Bansal, Nisha, et al.
Publicado: (2014)

Anxiety, Depression, and Adverse Clinical Outcomes in Patients With Atrial Fibrillation Starting Warfarin: Cardiovascular Research Network WAVE Study
por: Baumgartner, Christine, et al.
Publicado: (2018)

Cardiac Biomarkers and Risk of Atrial Fibrillation in Chronic Kidney Disease: The CRIC Study
por: Lamprea‐Montealegre, Julio A., et al.
Publicado: (2019)

Framingham and American College of Cardiology/American Heart Association Pooled Cohort Equations, High‐Sensitivity Troponin T, and N‐Terminal Pro–Brain‐Type Natriuretic Peptide for Predicting Atherosclerotic Cardiovascular Events Across the Spectrum of Kidney Dysfunction
por: Lidgard, Benjamin, et al.
Publicado: (2022)

Association of the Estimated Glomerular Filtration Rate With vs Without a Coefficient for Race With Time to Eligibility for Kidney Transplant
por: Zelnick, Leila R., et al.
Publicado: (2021)

Stability of High‐Quality Warfarin Anticoagulation in a Community‐Based Atrial Fibrillation Cohort: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study
por: Dallalzadeh, Liane O., et al.
Publicado: (2016)

Critical illness associated new onset atrial fibrillation: subsequent atrial fibrillation diagnoses and other adverse outcomes
por: Lancini, Daniel, et al.
Publicado: (2022)

Cardiac Biomarkers and Risk of Incident Heart Failure in Chronic Kidney Disease: The CRIC (Chronic Renal Insufficiency Cohort) Study
por: Bansal, Nisha, et al.
Publicado: (2019)

Risk of left atrial appendage thrombus in patients with atrial fibrillation and chronic kidney disease
por: Budnik, Monika, et al.
Publicado: (2022)

Risk factors for medication non-adherence among atrial fibrillation patients
por: Reading, Stephanie R., et al.
Publicado: (2019)

Chronic kidney disease and risks of adverse clinical events in patients with atrial fibrillation
por: LI, Si-Tong, et al.
Publicado: (2021)

Cardiac Biomarkers and Risk of Mortality in CKD (the CRIC Study)
por: Wang, Ke, et al.
Publicado: (2020)

Health Literacy and Awareness of Atrial Fibrillation
por: Reading, Stephanie R., et al.
Publicado: (2017)

Four‐year incidence of major adverse cardiovascular events in patients with atherosclerosis and atrial fibrillation
por: Miao, Benjamin, et al.
Publicado: (2020)

Atrial Fibrillation as a Possible Adverse Reaction to Evolocumab
por: Abdelmaseih, Ramy, et al.
Publicado: (2021)

Dose-limiting, adverse event–associated bradycardia with β-blocker treatment of atrial fibrillation in the GENETIC-AF trial
por: Abraham, William T., et al.
Publicado: (2021)

Atrial Fibrillation and Longitudinal Change in Cognitive Function in CKD
por: McCauley, Mark D., et al.
Publicado: (2021)

Effect of clinic-based single-lead electrocardiogram rhythm assessment on oral anticoagulation prescriptions in patients with previously diagnosed atrial fibrillation
por: Ashburner, Jeffrey M., et al.
Publicado: (2023)

Atrial Myopathy Underlying Atrial Fibrillation
por: Rivner, Harold, et al.
Publicado: (2020)

Peri-procedural anticoagulation in patients with end-stage kidney disease undergoing atrial fibrillation ablation: results from the multicentre end-stage kidney disease–atrial fibrillation ablation registry
por: Yamamoto, Tasuku, et al.
Publicado: (2023)

New‐onset atrial fibrillation in a young patient detected by smartwatch
por: Samal, Subhankar, et al.
Publicado: (2020)

New‐onset atrial fibrillation predicting for complicating cardiac adverse outcome in scrub typhus infection
por: Jang, Suk‐Yong, et al.
Publicado: (2019)

In-hospital acute kidney injury and atrial fibrillation: incidence, risk factors, and outcome
por: Wang, Guoqin, et al.
Publicado: (2021)

Anticoagulation in atrial fibrillation
por: Steinberg, Benjamin A, et al.
Publicado: (2014)

Genome and atrial fibrillation
por: Nakano, Yukiko
Publicado: (2023)

The anticoagulation length of therapy and risk of new adverse events in venous thromboembolism (ALTERNATIVE) study: Design and survey results
por: Portugal, Cecilia, et al.
Publicado: (2022)

Atrial Fibrosis, Ischaemic Stroke and Atrial Fibrillation
por: Mahnkopf, Christian, et al.
Publicado: (2021)

Associations Between Cardiac Biomarkers and Cardiac Structure and Function in CKD
por: Stein, Nathan R., et al.
Publicado: (2020)

Residual stroke risk despite oral anticoagulation in patients with atrial fibrillation
por: Carlisle, Matthew A., et al.
Publicado: (2022)

Ripple Frequency Determined via a Novel Algorithm Is Associated With Atrial Fibrillation Termination and Freedom From Atrial Fibrillation
por: Melby, Daniel P., et al.
Publicado: (2022)

Racial/ethnic and sex differences in safety outcomes and atrial fibrillation/atrial flutter–related acute healthcare utilization after catheter ablation of atrial fibrillation
por: Jackson, Larry R., et al.
Publicado: (2023)

Epidemiological characteristics, management, and outcomes of atrial fibrillation in TUNISIA: Results from the National Tunisian Registry of Atrial Fibrillation (NATURE‐AF)
por: Ouali, Sana, et al.
Publicado: (2021)

Validation of risk scores for ischaemic stroke in atrial fibrillation across the spectrum of kidney function
por: de Jong, Ype, et al.
Publicado: (2021)

Body Composition Changes Following Dialysis Initiation and Cardiovascular and Mortality Outcomes in CRIC (Chronic Renal Insufficiency Cohort): A Bioimpedance Analysis Substudy
por: Wang, Ke, et al.
Publicado: (2021)

Ablation of atrial fibrillation in an ambulatory outpatient setting
por: Willcox, Mark E., et al.
Publicado: (2023)

Smart detection of atrial fibrillation(†)
por: Krivoshei, Lian, et al.
Publicado: (2017)

Vitamin D Metabolic Ratio and Risks of Death and CKD Progression
por: Bansal, Nisha, et al.
Publicado: (2019)

Prediction of Incident Heart Failure in CKD: The CRIC Study
por: Zelnick, Leila R., et al.
Publicado: (2022)

Association of Obesity Measures with Atrial Fibrillation Recurrence After Cryoablation in Patients with Paroxysmal Atrial Fibrillation
por: Shang, Luxiang, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0hd2pqqafp8hfj42lvtpptnjmr